These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. Prakash P; Singh V; Jain M; Rana M; Khanna V; Barthwal MK; Dikshit M Eur J Pharmacol; 2014 Mar; 727():15-28. PubMed ID: 24486395 [TBL] [Abstract][Full Text] [Related]
24. Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. Li L; Hai J; Li Z; Zhang Y; Peng H; Li K; Weng X Food Chem Toxicol; 2014 Jan; 63():166-73. PubMed ID: 23978414 [TBL] [Abstract][Full Text] [Related]
25. Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes. Seo MS; Hong SW; Yeon SH; Kim YM; Um KA; Kim JH; Kim HJ; Chang KC; Park SW J Ethnopharmacol; 2014 Nov; 157():140-8. PubMed ID: 25261688 [TBL] [Abstract][Full Text] [Related]
26. Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products. Xu G; Huang K; Zhou J Curr Med Chem; 2018; 25(8):889-907. PubMed ID: 28393690 [TBL] [Abstract][Full Text] [Related]
27. Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism. Jegatheesan P; De Bandt JP Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273805 [TBL] [Abstract][Full Text] [Related]
28. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Rodriguez-Ramiro I; Vauzour D; Minihane AM Proc Nutr Soc; 2016 Feb; 75(1):47-60. PubMed ID: 26592314 [TBL] [Abstract][Full Text] [Related]
29. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
30. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Alwahsh SM; Gebhardt R Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280 [TBL] [Abstract][Full Text] [Related]
31. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592 [TBL] [Abstract][Full Text] [Related]
32. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Seo MS; Kim JH; Kim HJ; Chang KC; Park SW Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164 [TBL] [Abstract][Full Text] [Related]
33. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice. Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945 [TBL] [Abstract][Full Text] [Related]
34. New targets for NAFLD. Parlati L; Régnier M; Guillou H; Postic C JHEP Rep; 2021 Dec; 3(6):100346. PubMed ID: 34667947 [TBL] [Abstract][Full Text] [Related]
38. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). Mager DR; Iñiguez IR; Gilmour S; Yap J JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771 [TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. Wang Y; Li JY; Han M; Wang WL; Li YZ Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978 [TBL] [Abstract][Full Text] [Related]
40. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]